Leonardo Salese

Statistics

Publications

Citations

601

H-Index

Active since

2019

Affiliations

Pfizer (United States)(Current)

Icahn School of Medicine at Mount Sinai

Hospital Clínic de Barcelona

Università Cattolica del Sacro Cuore

University of California San Diego

Leonardo Salese is an author at Pfizer (United States) specializing in inflammatory bowel disease, ulcerative colitis pharmacotherapy, and inflammatory bowel disease therapy.

ORCID

Publications per year

2019–2025

Publications

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

Bruce E. Sands, Alessandro Armuzzi, John K. Marshall et al. · Alimentary Pharmacology & Therapeutics · 2019 · 85 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status

William J. Sandborn, Laurent Peyrin‐Biroulet, Ala I. Sharara et al. · Clinical Gastroenterology and Hepatology · 2021 · 71 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe

Alessandro Armuzzi, Marco daCosta DiBonaventura, M. Tarallo et al. · PLoS ONE · 2020 · 59 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe

Alessandro Armuzzi, M. Tarallo, James Lucas et al. · BMC Gastroenterology · 2020 · 45 citations · Full text

Pharmacy, Internal Medicine, Gastroenterology +16

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme

Kevin Winthrop, Edward V. Loftus, Daniel C. Baumgart et al. · Journal of Crohn s and Colitis · 2020 · 40 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

1–5 of 16